Companies: 10,795·Total market cap: $144.5T
Moleculin Biotech, Inc.

Moleculin Biotech, Inc.

MBRXNASDAQHealthcare● Active
$2.47
+$0.07(+2.92%)
Market Cap$2986526
P/E Ratio
52W High$24
52W Low$1.79
Overview

Moleculin Biotech, Inc. (MBRX) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · MBRX · as of Jun 8, 2026

Activity summary

Buy transactions

4

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Moleculin Biotech, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

MBRX insider buying and selling by quarter

MBRX insider selling · MBRX insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
3.8M1.9M0
2024 Q3
2024 Q4
2025 Q2
2025 Q4

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · MBRX ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

MBRX executive sell shares · MBRX board member insider trading · MBRX insider trading SEC filing

Showing 49 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

PICKER DONALD H

Chief Science Officer

Option

Date

Nov 4

Shares

8,750

Price

Value

View Form 4 on SEC.gov

PICKER DONALD H

Chief Science Officer

Other

Date

Nov 4

Shares

2,131

Price

$0.50

Value

$1K

View Form 4 on SEC.gov

KLEMP WALTER V

CEO and President · Director

Option

Date

Nov 4

Shares

28,750

Price

Value

View Form 4 on SEC.gov

KLEMP WALTER V

CEO and President · Director

Other

Date

Nov 4

Shares

7,001

Price

$0.50

Value

$3K

View Form 4 on SEC.gov

Foster Jonathan P.

CFO

Option

Date

Nov 4

Shares

20,625

Price

Value

View Form 4 on SEC.gov

Foster Jonathan P.

CFO

Option

Date

Nov 4

Shares

5,023

Price

$0.50

Value

$2K

View Form 4 on SEC.gov

Foster Jonathan P.

CFO

Purchase

Date

Jun 23

Shares

270,270

Price

$0.37

Value

$100K

View Form 4 on SEC.gov

Foster Jonathan P.

CFO

Option

Date

Jun 22

Shares

4,328

Price

Value

View Form 4 on SEC.gov

Foster Jonathan P.

CFO

Other

Date

Jun 22

Shares

1,054

Price

$0.27

Value

$281

View Form 4 on SEC.gov

Foster Jonathan P.

CFO

Option

Date

Jun 20

Shares

2,711

Price

Value

View Form 4 on SEC.gov

Foster Jonathan P.

CFO

Other

Date

Jun 20

Shares

661

Price

$0.27

Value

$176

View Form 4 on SEC.gov

KLEMP WALTER V

CEO and President · Director

Purchase

Date

Jun 23

Shares

675,675

Price

$0.37

Value

$250K

View Form 4 on SEC.gov

KLEMP WALTER V

CEO and President · Director

Option

Date

Jun 22

Shares

8,990

Price

Value

View Form 4 on SEC.gov

KLEMP WALTER V

CEO and President · Director

Other

Date

Jun 22

Shares

2,190

Price

$0.27

Value

$585

View Form 4 on SEC.gov

KLEMP WALTER V

CEO and President · Director

Option

Date

Jun 20

Shares

3,750

Price

Value

View Form 4 on SEC.gov

KLEMP WALTER V

CEO and President · Director

Other

Date

Jun 20

Shares

914

Price

$0.27

Value

$244

View Form 4 on SEC.gov

PICKER DONALD H

Chief Science Officer

Option

Date

Jun 22

Shares

1,766

Price

Value

View Form 4 on SEC.gov

PICKER DONALD H

Chief Science Officer

Other

Date

Jun 22

Shares

430

Price

$0.27

Value

$115

View Form 4 on SEC.gov

PICKER DONALD H

Chief Science Officer

Option

Date

Jun 20

Shares

1,078

Price

Value

View Form 4 on SEC.gov

PICKER DONALD H

Chief Science Officer

Other

Date

Jun 20

Shares

263

Price

$0.27

Value

$70

View Form 4 on SEC.gov

Foster Jonathan P.

CFO

Option

Date

Jun 16

Shares

833

Price

Value

View Form 4 on SEC.gov

Foster Jonathan P.

CFO

Other

Date

Jun 16

Shares

203

Price

$0.69

Value

$139

View Form 4 on SEC.gov

KLEMP WALTER V

CEO and President · Director

Option

Date

Jun 16

Shares

1,667

Price

Value

View Form 4 on SEC.gov

KLEMP WALTER V

CEO and President · Director

Other

Date

Jun 16

Shares

406

Price

$0.69

Value

$278

View Form 4 on SEC.gov

KLEMP WALTER V

CEO and President · Director

Option

Date

Jul 2

Shares

982

Price

Value

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About MBRX insider trading

MBRX insider trades

Moleculin Biotech, Inc. (MBRX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including KLEMP WALTER V (CEO and President · Director), Foster Jonathan P. (CFO), PICKER DONALD H (Chief Science Officer). Over the past 12 months, 3 insiders have filed transactions with the SEC. MBRX insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Moleculin Biotech, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

MBRX insider trading · 5 questions

The insiders of Moleculin Biotech, Inc. (MBRX) include executives and directors such as KLEMP WALTER V (CEO and President · Director), Foster Jonathan P. (CFO), PICKER DONALD H (Chief Science Officer), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

MBRX board member insider tradingwho are MBRX insidersMBRX insider rosterMoleculin Biotech, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026